Weighted Average Number of Shares Outstanding, Basic of Edesa Biotech, Inc. from 31 Aug 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Edesa Biotech, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Aug 2013 to 31 Dec 2025.
  • Edesa Biotech, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 7,972,532, a 138% increase year-over-year.
  • Edesa Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 5,676,708, a 78% increase from 2024.
  • Edesa Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 3,197,423, a 12% increase from 2023.
  • Edesa Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2,858,929.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Edesa Biotech, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 7,972,532 +4,627,397 +138% 01 Oct 2025 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q3 2025 5,676,708 +2,479,285 +78% 01 Jul 2025 30 Sep 2025 10-K 12 Dec 2025 2025 FY
Q2 2025 7,022,678 +3,800,872 +118% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q3
Q1 2025 5,305,763 +2,113,075 +66% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 3,345,135 +217,111 +6.9% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2026 2026 Q1
Q3 2024 3,197,423 01 Jul 2024 30 Sep 2024 10-K 12 Dec 2025 2025 FY
Q2 2024 3,221,806 +291,125 +9.9% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q3
Q1 2024 3,192,688 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q2
Q4 2023 3,128,024 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q1
Q2 2023 2,930,681 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q3
Q2 2016 8,448,758 +494,093 +6.2% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2016 2016 Q3
Q3 2015 7,956,962 +89,387 +1.1% 01 Jul 2015 30 Sep 2015 10-K 14 Dec 2016 2016 FY
Q2 2015 7,954,665 -68,282,790 -90% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q3
Q1 2015 79,546,650 +3,309,195 +4.3% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015 2015 Q2
Q4 2014 79,461,013 +5,482,277 +7.4% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2015 2015 Q1
Q3 2014 7,867,575 01 Sep 2014 30 Sep 2014 10-K 14 Dec 2016 2016 FY
Q2 2014 76,237,455 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q3
Q1 2014 76,237,455 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q2
Q4 2013 73,978,736 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015 2015 Q1

Edesa Biotech, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 5,676,708 +2,479,285 +78% 01 Oct 2024 30 Sep 2025 10-K 12 Dec 2025 2025 FY
2024 3,197,423 +338,494 +12% 01 Oct 2023 30 Sep 2024 10-K 12 Dec 2025 2025 FY
2023 2,858,929 01 Oct 2022 30 Sep 2023 10-K 13 Dec 2024 2024 FY
2016 8,826,312 +869,350 +11% 01 Oct 2015 30 Sep 2016 10-K 14 Dec 2016 2016 FY
2015 7,956,962 +374,298 +4.9% 01 Oct 2014 30 Sep 2015 10-K 14 Dec 2016 2016 FY
2014 7,582,664 +2,421,470 +47% 01 Sep 2013 31 Aug 2014 10-K 14 Dec 2016 2016 FY
2013 5,161,194 01 Sep 2012 31 Aug 2013 10-K 14 Dec 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.